Concepedia

Chloé Tesmoingt

CT

7

Publications

269

Citations

7

H-Index

2007

Active since

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Sorbonne Université

Université Claude Bernard Lyon 1

Hôpital Bichat-Claude-Bernard

Hôpital Saint-Antoine

Chloé Tesmoingt is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, health sciences, and nursing.

Top concepts

Publications per year

2007–2022

7

Publications

7

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma

Amani Asnacios, Olivier Romano, Chloé Tesmoingt et al. · Cancer · 2008 · 138 citations

Enzyme therapy in Fabry disease: severe adverse events associated with anti‐agalsidase cross‐reactive IgG antibodies

Chloé Tesmoingt, Olivier Lidove, Axele Reberga et al. · British Journal of Clinical Pharmacology · 2009 · 32 citations · Full text

Medication Reconciliation: A Prospective Study in an Internal Medicine Unit

Laura Andréoli, Jean‐François Alexandra, Chloé Tesmoingt et al. · Drugs & Aging · 2014 · 26 citations

, , +8

Gemcitabine, oxaliplatin (GEMOX) and cetuximab for treatment of hepatocellular carcinoma (HCC): Results of the phase II study ERGO

Sami Louafi, Mohamed Hebbar, Olivier Rosmorduc et al. · Journal of Clinical Oncology · 2007 · 23 citations

, , +16

Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study

Raphaël Borie, Laurent Savale, Antoine Dossier et al. · PLoS ONE · 2020 · 20 citations · Full text

Rows per page

1–5 of 7